Surgeon-led hair restoration clinic in Levent, Istanbul since 2007.
Explore all →Send 3–5 photographs. Personal response within 24 hours — no intermediaries.
Request Now →Selected for your specific hair loss pattern and aesthetic goals.
FUE vs DHI →FUE, DHI or Algorithmic FUE™ — Dr. Arslan recommends based on your photographs and Norwood stage.
Get Assessment → Try Graft Calculator →FUE Europe member. Ministry of Health accredited clinic. Levent, Istanbul — 60–80% less than UK or US.
View Package →FUE Europe member. Ministry of Health accredited. 17+ years. 4,500+ personal procedures. One patient per day.
Full Profile →Every graft personally placed. Every result personally accountable.
Read Philosophy →No hidden costs. Hotel, transfers, surgery and aftercare in one price.
View Pricing →Silver · Gold · VIP — 5-star hotel · Airport transfers · PRP included
View Pricing → Graft Calculator →Not every case needs a transplant. Medical treatments, therapies and specialist options.
Overview →Guides, tools and expert content — written by Dr. Arslan Musbeh.
All Articles →
Central Centrifugal Cicatricial Alopecia (CCCA) is a progressive scarring hair loss condition that begins at the crown of the scalp and spreads outward in a centrifugal (radiating outward) pattern. It almost exclusively affects Black women, with estimates suggesting it affects up to 17% of Black women in the United States.
CCCA causes permanent hair loss because the inflammatory process destroys the hair follicle and replaces it with scar tissue (fibrosis). Unlike androgenetic alopecia — where the follicle miniaturises but survives — in CCCA the follicle is permanently eliminated. Once an area has fully scarred, no medical treatment can restore follicle function.
The condition is associated with: tight hairstyling practices (particularly chemical relaxers combined with heat and tension), possible genetic predisposition, and certain hair care products. Its exact aetiology remains under active research.
Hair transplant for CCCA is possible — but only under very specific conditions:
The disease must be inactive. Active CCCA involves ongoing follicular inflammation that will destroy newly transplanted grafts just as it has destroyed the native follicles. A minimum of 12–24 months of confirmed disease inactivity is required before surgery is considered. Inactivity is confirmed by scalp biopsy or trichoscopy examination showing no active inflammation.
The donor area must be unaffected. CCCA primarily affects the crown and vertex. In most patients, the donor zone at the back and sides of the scalp remains fully intact and available for harvest.
Realistic expectations are essential. Transplanting into scarred scalp tissue produces lower graft survival rates (typically 70–85%) than transplanting into healthy tissue. Patients must understand that the result may require a second session to achieve adequate density.
Before any surgical consultation for CCCA, dermatological management is required to halt disease progression. Current treatment options for active CCCA include: topical and intralesional corticosteroids, oral tetracycline antibiotics (doxycycline), topical calcineurin inhibitors, and low-dose oral minoxidil to protect non-scarred hair.
Dr. Arslan coordinates with the patient's dermatologist or trichologist before planning any CCCA case. The surgical and medical teams must confirm disease inactivity before a consultation for transplant surgery is scheduled.
Hairmedico accepts CCCA consultations from Black women who have achieved documented disease remission. Dr. Arslan's protocol for CCCA cases includes: review of biopsy results or trichoscopy documentation of inactivity; a test session of 100–150 grafts with 3-month observation before a full procedure; DHI technique for placement into the scarred recipient zone; and extended 12-month follow-up with monthly photograph review to detect any recurrence of inflammation that would threaten the transplanted grafts.
Yes. Women are good candidates when hair loss meets clinical criteria: stable pattern, adequate donor density, appropriate underlying cause (genetic, traction, post-inflammatory). DHI technique is often preferred for women as it works between existing hairs without requiring full shaving.
Female androgenetic alopecia (Ludwig pattern), traction alopecia from tight hairstyles, and post-inflammatory hair loss from inactive scarring alopecia are the main treatable causes. Diffuse telogen effluvium and active autoimmune alopecia require medical management before considering surgery.
Not with DHI technique. Hairmedico's unshaved DHI places grafts between existing hairs without cutting surrounding hair. The transplanted hair integrates naturally and the procedure is completely discreet during recovery.
This varies significantly by pattern. Frontal hairline thinning: 800–1,500 grafts. Diffuse thinning over the entire top: 2,000–3,500 grafts. Traction alopecia in the temple and edge zone: 500–1,200 grafts. Trichoscopy assessment provides a precise recommendation.
Hairmedico all-inclusive: price on request for 2,000–3,500 grafts including surgery, 5-star hotel, transfers, PRP and 12-month follow-up.
Yes. Transplanted follicles are DHT-resistant and grow permanently for the patient's lifetime.
Desk work: 5–7 days. Scabs shed by Day 10–14. New growth from months 3–5. Final result months 12–14.
Dr. Arslan Musbeh personally — every extraction, every channel, every graft. One patient per day.
Yes, with an accredited surgeon-led clinic. Verify FUE Europe membership, Ministry of Health registration, and confirm the surgeon personally operates.
All references are peer-reviewed medical literature or official health authority publications. No commercial sources included.
Dr. Arslan Musbeh — Afro hair specialist. Send 3 photos for a personal evaluation within 24h.
WhatsApp →